학술논문

Prostate cancer research in the 21st century; report from the 2021 Coffey‐Holden prostate cancer academy meeting
Document Type
article
Source
The Prostate. 82(2)
Subject
Biomedical and Clinical Sciences
Clinical Sciences
Oncology and Carcinogenesis
Immunology
Human Genome
Prostate Cancer
Cancer Genomics
Cancer
Urologic Diseases
Aging
Genetics
Congresses as Topic
Humans
Immunotherapy
Male
Prostate
Prostatic Neoplasms
Research
cancer immunotherapy
molecular imaging
precision medicine
therapeutics
tumor genomics
Paediatrics and Reproductive Medicine
Oncology & Carcinogenesis
Clinical sciences
Oncology and carcinogenesis
Language
Abstract
IntroductionThe 2021 Coffey-Holden Prostate Cancer Academy (CHPCA) Meeting, "Prostate Cancer Research in the 21st Century," was held virtually, from June 24-25, 2021.MethodsThe CHPCA Meeting is organized by the Prostate Cancer Foundation as a unique discussion-oriented meeting focusing on critical topics in prostate cancer research envisioned to bridge the next major advances in prostate cancer biology and treatment. The 2021 CHPCA Meeting was virtually attended by 89 investigators and included 31 talks over nine sessions.ResultsMajor topic areas discussed at the meeting included: cancer genomics and sequencing, functional genomic approaches to studying mediators of plasticity, emerging signaling pathways in metastatic castration resistant prostate cancer, Wnt signaling biology and the challenges of targeted therapy, clonal hematopoiesis, neuroendocrine cell plasticity and antitumor immunity, cancer immunotherapy and its synergizers, and imaging the tumor microenvironment and metabolism.DiscussionThis meeting report summarizes the research presented at the 2021 CHPCA Meeting. We hope that publication of this knowledge will accelerate new understandings and the development of new biomarkers and treatments for prostate cancer.